V-935

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameV-935
Drug Alias NameV934V935V934/V935V-934V-935
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunostimulantsTelomerase reverse transcriptase inhibitors
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGeron CoMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 

Other Information

ATC CodeN/A
Related LinksN/A